Pulse oximetry screening for critical congenital heart defects: a European consensus statement
2017; Elsevier BV; Volume: 1; Issue: 2 Linguagem: Inglês
10.1016/s2352-4642(17)30066-4
ISSN2352-4650
AutoresPaolo Manzoni, Gerard R. Martin, Manuel Sánchez Luna, Julije Meštrović, Umberto Siméoni, Luc J. I. Zimmermann, Andrew K Ewer, Paolo Manzoni, Gerard R. Martin, Anne de‐Wahl Granelli, Avroy A. Fanaroff, Luc J. I. Zimmermann, Ilona C. Narayen, Danièle De Luca, Julie Thomas-Chabaneix, Thorsten Orlikowsky, Umberto Siméoni, I. Soldatova, Julije Meštrović, Barry Rodgers‐Gray, Virgilio Carnielli, Antonio Del Vecchio, Sergio Picardo, Robert Tulloh, Máximo Vento, Manuel Sánchez Luna, Andrew K Ewer,
Tópico(s)Ultrasound in Clinical Applications
ResumoCritical congenital heart defects (CCHD), which require intervention in the first few weeks of life, occur in about two in 1000 livebirths and are an important cause of neonatal mortality and morbidity.1–3 Surgical and catheter interventions now lead to excellent outcomes for most cases of CCHD, but timely detection is essential.3 Existing screening strategies for newborn babies, including antenatal ultrasound and postnatal examination, do not detect CCHD before discharge in up to one-third of cases, and many of these infants will either collapse or die before diagnosis.
Referência(s)